Takeda Vietnam awarded for ongoing support of Vietnam’s sustainability efforts

Takeda Vietnam awarded for ongoing support of Vietnam’s sustainability efforts

Takeda Vietnam has received the “In Partnership with Vietnam’s Sustainable Development” award.
Vietnam advances three-pillar strategy to prevent cervical cancer

Vietnam advances three-pillar strategy to prevent cervical cancer

Vietnam is stepping up vaccination, screening and timely follow-up as part of a national push to eliminate cervical cancer by 2030.
Experts warn of unpredictable severity of dengue fever

Experts warn of unpredictable severity of dengue fever

Dengue fever is becoming increasingly difficult to predict in terms of timing and outbreak scale.
Technical mastery offered with nation’s ASF vaccine production

Technical mastery offered with nation’s ASF vaccine production

Alongside research and production of vaccines to prevent African swine fever, Vietnam is increasingly mastering the necessary technology and exporting products to other markets.
Integrated solutions for dengue fever prevention in Vietnam

Integrated solutions for dengue fever prevention in Vietnam

Synchronised implementation of multiple solutions is needed to ensure sustainability of dengue fever vaccines.
Takeda’s partnerships to deliver innovative medicine and vaccines

Takeda’s partnerships to deliver innovative medicine and vaccines

Global biopharmaceutical company Takeda is deepening collaboration with stakeholders to deliver innovative healthcare solutions in Vietnam, underscoring its commitment to creating sustainable values for the community.
Takeda honoured for contributions to Vietnam's sustainable development

Takeda honoured for contributions to Vietnam's sustainable development

With over a decade of pioneering solutions in Vietnam’s pharmaceutical sector, Takeda has been recognised for its contributions to sustainable development.
Experts discuss dengue fever prevention in Vietnam

Experts discuss dengue fever prevention in Vietnam

Takeda, a global biopharmaceutical company, hosted meetings in Ho Chi Minh City and Hanoi on September 26-27 to discuss a dengue prevention strategy.
Takeda delivering transformative healthcare solutions

Takeda delivering transformative healthcare solutions

At the VIR health conference- "Empowering health innovation for sustainability vision" held on September 25, 2024, Dion Warren – area head of India and Southeast Asia (I-SEA) of Takeda, emphasised Takeda's commitment in delivering transformative healthcare solutions for lasting social value.
Indonesia plans to develop homegrown vaccine against dengue fever

Indonesia plans to develop homegrown vaccine against dengue fever

Indonesia’s National Research and Innovation Agency (BRIN) plans to initiate the development of a homegrown dengue hemorrhagic fever (DBD) vaccine.
FPT Retail enters Vietnam's vaccine sector

FPT Retail enters Vietnam's vaccine sector

FPT Retail has expanded its healthcare portfolio with five new vaccination centres, positioning itself in a market that is witnessing increasing demand.
AstraZeneca’s COVID-19 vaccine preventing over 230,000 deaths in Vietnam

AstraZeneca’s COVID-19 vaccine preventing over 230,000 deaths in Vietnam

AstraZeneca’s COVID-19 vaccine has been estimated to have prevented 232,766 deaths in Vietnam, according to an independent assessment of vaccine effectiveness conducted by Airfinity.
World’s first vaccine developed for ASF

World’s first vaccine developed for ASF

Vietnam has successfully developed a vaccine to administer to pigs to fight African swine fever, with the aim of becoming the first country in the world to commercially produce and export it.
Vietnam steps closer to African swine fever vaccine

Vietnam steps closer to African swine fever vaccine

A Vietnamese-made commercial vaccine for African swine fever is expected in the next few months, after long delays.
COVID-19 recovery index of Vietnam soars by 28 places

COVID-19 recovery index of Vietnam soars by 28 places

Vietnam climbed a total of 28 notches to reach rank 90 in the latest edition of Nikkei's COVID-19 Recovery Index thanks to the high vaccine coverage rate.
|< < 1 2 3 4 > >|